Alembic Pharmaceuticals Limited (NSE:APLLTD)
India · Delayed Price · Currency is INR 760.25
-21.05 (-2.69%)
Oct 23, 2026, 11:38 AM IST
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 149.44 billion as of October 22, 2026. It is the 7,506th most valuable company in the world and the 429th biggest in India. Its market cap has decreased by 18.50% in one year.
Market Cap
149.44B
Enterprise Value
161.71B
Revenue
77.84B
Global Rank
Country Rank
#429 India
PE Ratio
21.55
ChartMarket Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 149.44B, an increase of 1,560.11%. That is a compound annual growth rate of 20.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 149.44B | -10.15% |
| Dec 31, 2025 | 166.32B | -20.64% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 335.09B |
| Wockhardt | 309.76B |
| Piramal Pharma | 258.46B |
| Cohance Lifesciences | 175.11B |
| Alivus Life Sciences | 155.71B |
| Eris Lifesciences | 155.44B |
| NATCO Pharma | 143.44B |
| Sudeep Pharma | 113.32B |